Abstract
Aims/hypothesisOur aim was to investigate the relationship between average blood glucose levels and incident CHD in individuals without diabetes mellitus.MethodsTo investigate average blood glucose levels, we studied HbA1c as predicted by 40 variants previously shown to be associated with both type 2 diabetes and HbA1c. Linear and non-linear Mendelian randomisation analyses were performed to investigate associations with incident CHD risk in 324,830 European ancestry individuals from the UK Biobank without diabetes mellitus.ResultsEvery one mmol/mol increase in genetically proxied HbA1c was associated with an 11% higher CHD risk (HR 1.11, 95% CI 1.05, 1.18). The dose-response curve increased at all levels of HbA1c, and there was no evidence favouring a non-linear relationship over a linear one.Conclusions/interpretationsIn individuals without diabetes mellitus, lowering average blood glucose levels may reduce CHD risk in a dose-dependent way.Graphical abstract